Welltower rises 1.4% after Q3 results, FFO beats estimates but EPS misses

What happened

Welltower (WELL) rose 1.4% on October 26, 2026, after third-quarter results showed stronger cash-flow metrics but weaker GAAP earnings. The company reported quarterly normalized FFO of $1.67 per diluted share, above the Zacks Consensus Estimate of $1.64, while diluted earnings per share were $0.54 against $0.64 expected, 15.8% below estimates. Trading volume was 0.9 times its 20-day average as the S&P 500 rose 0.7% on the day.

How big was the move

The stock’s closing price was $240.61, a rise of 1.4% on the session and 3.0% over the last five sessions. The move amounted to 1.2 times a typical daily move for this stock and was 1.3 percentage points better than the Real Estate sector median, which rose 0.1% on the day. Market sensitivity is low, with a beta of 0.25, and the S&P 500 over the five-session span fell 0.2%.

The session reaction was driven by the earnings release. The FFO beat and the EPS miss give investors mixed signals: the cash-flow measure surpassed estimates while the GAAP earnings figure fell short. That divergence tends to sharpen debate among income-focused and earnings-focused investors about the stock’s near-term outlook.

The technical picture

The stock closed 4.1% above its 20-day moving average and 2.9% above its 50-day moving average, while it was 10.6% above its 200-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend, and the stock has been above the 200-day average for 891 consecutive trading days. The Relative Strength Index (14 days) read 62, inside a neutral range, and the share price sat 5.7% below its 52-week high.

Shorter-term volatility was subdued: annualized volatility over 60 days was 19%, lower than 82% of its own readings over five years. Over one month the stock rose 4.0%, over three months it fell 1.2%, and over one year it rose 36.7%, which is 22.7 percentage points ahead of the S&P 500. Those figures underscore the stock’s strong momentum and unusually low sensitivity to market swings.

Fundamentals and valuation

For the four quarters through September 30, 2026, revenue was $13.70 billion, which grew 40.5% from a year earlier and accelerated from growth of 38.1% one quarter earlier. Diluted earnings per share for the period were $2.03, which rose 41.0% from a year earlier. Gross margin was 28.1%, down from 38.8% a year earlier, and operating margin was 4.5%, down from 16.2% a year earlier. Free-cash-flow margin stood at 13.2% and return on invested capital was 1.0%.

The balance sheet showed net debt of 0.4 times EBITDA, and share count increased by 10.1% over one year. Those figures point to modest leverage but notable share dilution over the past year. Valuation metrics show a price to trailing earnings of 118.5 times trailing earnings and a price to forward earnings of 84.3 times expected earnings. Free-cash-flow yield was 1.1%.

Measured against its own history, the current price to trailing earnings was higher than 52% of its own readings over the past five years, with a five-year median of 117.6 times earnings. That places the stock near its historical midpoint on that metric, signaling neither a deep discount nor an extreme premium relative to its recent history.

Earnings and analyst expectations

Welltower reported on October 26, 2026, that net income was $415 million and net income attributable to common stockholders was $0.54 per diluted share for the quarter. Quarterly normalized FFO of $1.67 per diluted share beat the Zacks Consensus Estimate of $1.64 and compared with FFO of $1.34 a year earlier. The EPS result of $0.54 was 15.8% below the $0.64 expected.

Consecutive quarters beating estimates is zero, and the average surprise over the last four reports was 10.6% below estimates. Typical two-day reactions after recent reports have been modest, with the stock rising 0.7% on average following earnings releases. Analysts place a consensus price target of $257.23, 6.9% above the closing price, based on ratings from 36 analysts. Seventy-eight percent of those ratings classify the stock as Buy or Strong Buy, and the consensus rating is Buy. The next scheduled report is February 9, 2027.

What to watch

• Quarterly normalized FFO of $1.67 per diluted share reported Oct. 26, 2026, versus a Zacks Consensus Estimate of $1.64
• Diluted EPS of $0.54 on Oct. 26, 2026, 15.8% below the $0.64 expected
• Next earnings report scheduled Feb. 9, 2027
• Consensus price target $257.23, 6.9% above the closing price
• PromtFinance scores: Growth 92, Momentum 95, Stability 99, Value 13, Quality 23, Revisions 28